Comprehensive Stool Analysis (CDSA): What It Is and What It Finds

Ask a functional or integrative practitioner for "gut testing" and the phrase you will hear back is comprehensive stool analysis — often by its acronym, CDSA. It is not one product but a category of laboratory panel built to answer a deliberately broad question: what is going on in this gut, across digestion, inflammation and the microbial ecosystem, all at once? That breadth is the point — and the reason a comprehensive panel is not automatically the right purchase.

What a comprehensive stool analysis is

A comprehensive stool analysis is a single stool sample examined across multiple domains rather than for one suspect. A targeted test asks one question — is H. pylori present? A clinical PCR pathogen panel asks a slightly wider one: which acute infection explains this diarrhea? A comprehensive panel instead surveys the territory: whether you are digesting food properly, whether the gut lining is inflamed, whether the immune system of the gut is underpowered or overreacting, which pathogens, parasites and fungi are present, and whether the resident bacteria are in reasonable balance.

The term CDSA, for Comprehensive Digestive Stool Analysis, started life as the proper name of an early commercial panel and drifted into generic use. Today practitioners use it loosely for any broad stool panel, whatever technology it uses — and the technology is the variable worth understanding.

The classic CDSA versus modern molecular panels

The classic CDSA of the 1990s and 2000s was built from three tools. Culture: stool spread on growth plates to see which organisms grow. Microscopy: a technician examining slides for ova and parasites. Chemistry: assays for digestion markers such as fecal fats and enzymes. It was genuinely useful, and it had genuine blind spots — most gut bacteria are anaerobes that will not grow on a culture plate, and microscopy depends on an organism being present, intact and recognized on the slide. Parasites that shed intermittently classically required two or three separate samples.

Modern comprehensive panels such as the GI-MAP™ (Gastrointestinal Microbial Assay Plus) replace culture and microscopy with quantitative PCR: the lab detects the DNA of defined target organisms and reports how much of each was found. Organisms that never grew on plates are measurable, one sample suffices, and the output is a number rather than a technician's read. Fairness requires the reverse column too: an organism grown in culture can be tested directly against antibiotics, which no DNA panel replaces; a microscopist can spot something that is not on a panel's target list; and some laboratories' traditional panels report chemistry, such as short-chain fatty acids, that the GI-MAP™ does not. Neither generation of test is a diagnosis — both produce data for a practitioner to interpret.

What a comprehensive stool test measures, category by category

Digestion and absorption

Pancreatic elastase-1 reflects pancreatic enzyme output; low values are associated with poor digestion of fat and protein. Steatocrit measures fat actually left in the stool — the downstream evidence. Beta-glucuronidase is a bacterial enzyme practitioners consider in the context of estrogen and toxin recirculation.

Inflammation and immune markers

Calprotectin is the flagship: an inflammation marker used widely in conventional gastroenterology, where markedly elevated values prompt escalation to a GI physician (the NIH's MedlinePlus has a plain-language explainer). Secretory IgA reflects the gut's own antibody defense — low and high both carry meaning. Anti-gliadin IgA is a marker of immune reaction to gluten, not a celiac diagnosis. Occult blood screens for hidden bleeding, and zonulin, an optional add-on, is used to assess gut-barrier integrity.

Microbiology: pathogens, commensals and opportunists

Three layers. Bacterial and viral pathogens — the organisms nobody should host at high levels. H. pylori with its virulence factors, which help a practitioner judge how aggressive a strain may be. And the resident flora: normal commensals such as Akkermansia muciniphila and Faecalibacterium prausnitzii, where low counts matter as much as high ones, plus opportunistic bacteria that are tolerable at low levels and troublesome when overgrown — a pattern relevant to IBS and SIBO workups.

Parasitology and fungi

qPCR targets for parasites including Giardia, Cryptosporidium and Blastocystis, plus fungal organisms including Candida. Because detection is DNA-based, it does not depend on catching a live, intact organism under a microscope on the right day.

Antibiotic-resistance genes

The panel also reports genes associated with antibiotic resistance. This informs a prescriber's thinking about which drug families may fail; it does not replace culture-based susceptibility testing, and no stool test tells you on its own whether antibiotics are warranted at all.

Which marker answers which question

The full catalogue, marker by marker, lives in the biomarker guides, and the sample report shows how each appears on the page you would actually receive.

How the GI-MAP™ compares to a traditional CDSA

Same intent, different instruments. The GI-MAP™ is a comprehensive stool analysis in every functional sense — digestion, inflammation, immunity, microbiology, parasitology — executed entirely by qPCR at Diagnostic Solutions Laboratory, a CLIA-certified lab in Alpharetta, Georgia. Against the traditional format you gain quantified DNA detection of organisms culture cannot grow, single-sample collection at home, and results roughly 10–14 business days after the lab receives your sample. You give up culture-based susceptibility testing and the open-ended eye of a microscopist. The honest comparison with a conventional physician-ordered panel is in stool PCR vs GI-MAP; the collection logistics are in our stool test kit walkthrough.

Do you actually need a full stool analysis?

Not everyone does, and it would be easy money to pretend otherwise. A comprehensive panel earns its price when symptoms are chronic and unexplained — the bloating, irregularity and food reactions that have survived a conventional workup — and when a practitioner is ready to act on the results. It is also the right shape of test when several questions need answering at once — running targeted tests one by one gets slow and expensive.

It is the wrong purchase in three common cases. If your only question is H. pylori, the targeted H. Pylori Profile at $237 answers it for less than half the cost. If you are acutely and severely ill, see a doctor — an insurance-billed hospital GI panel is faster and built for that job. And if you have no symptoms and are simply curious about your microbiome, a cheaper 16S census kit is genuinely fine; our microbiome test and gut health test guides explain that choice, and is the GI-MAP worth it makes the case against us where it applies.

What comprehensive stool analysis costs

The GI-MAP™ Standard is $525; the GI-MAP™ + Zonulin is $600. Both include the kit, free US shipping, the practitioner order and the lab analysis; Klarna splits either into four payments, and the test is generally HSA/FSA eligible. A practitioner-written analysis of your results is the separate, optional Interpretation Review at $245; our free interpretive guide covers reading the report yourself. Full line items are on the cost page; note the test cannot be ordered in New York, New Jersey or Rhode Island.

Comprehensive stool analysis FAQ

What is a comprehensive stool analysis?

A comprehensive stool analysis is a laboratory panel that evaluates many dimensions of gut health from a single stool sample — typically digestion and absorption markers, inflammation and immune markers, the balance of normal bacteria, and screening for pathogens, parasites and fungi. It answers a broad question about the whole gut ecosystem, where a targeted test answers one narrow question.

What does CDSA stand for?

CDSA stands for Comprehensive Digestive Stool Analysis. It began as the proper name of an early culture-and-chemistry panel and has since become the generic term practitioners use for any broad stool panel, including modern qPCR tests such as the GI-MAP.

What is the best comprehensive stool test?

It depends on what you need measured. If you want quantified results on pathogens, parasites, fungi, H. pylori with virulence factors, commensal bacteria and intestinal health markers from one at-home sample, the GI-MAP is one of the most complete qPCR panels available. If your question is narrower — H. pylori alone, for example — a targeted profile costs less than half as much. And if you are simply curious about your microbiome, a cheaper 16S sequencing kit is honestly fine.

What's the difference between a CDSA and the GI-MAP?

A traditional CDSA identifies organisms by growing them in culture and examining stool under a microscope, with chemistry tests for digestion markers. The GI-MAP covers the same territory with quantitative PCR, which detects and quantifies the DNA of defined targets, including anaerobic bacteria that culture cannot grow. Culture keeps one real advantage: an organism grown on a plate can be tested directly for antibiotic susceptibility, which a DNA panel cannot fully replace.

How much does a comprehensive stool analysis cost?

The GI-MAP costs $525, or $600 with the zonulin add-on, including free US shipping and the practitioner order the test requires. Prices for comprehensive panels vary widely between laboratories and between the practitioners who resell them, so compare the total at checkout, whether shipping both ways is included, and whether the practitioner order is included or costs extra. A conventional stool workup ordered by your doctor for an acute illness is usually billed to insurance, but it answers a narrower question.

Related: Stool test kit · Interpretive guide · Stool PCR vs GI-MAP · Cost · Biomarkers